We help biotech, pharma, and diagnostics teams avoid pathology workflow failures that derail timelines and compromise data quality. IHC assay design, tissue management, digital pathology workflows, and pathology review.
Our consulting is informed by hands-on experience across histopathology, immunohistochemistry, and digital pathology workflows. We understand real laboratory operations, not just theory.
We design solutions for real-world constraints including limited samples, fixed timelines, and regulatory scrutiny. Our recommendations work within your actual operational parameters.
Our recommendations are designed for real-world constraints—not idealized lab conditions. We bridge the gap between best practices and what's actually achievable in your environment.
Expert pathology consulting for biotech, pharma, and diagnostics companies.
Protocol design, antibody validation, and assay optimization for FFPE and fresh samples.
Learn More →Biomarker discovery, evaluation, and research-stage analysis.
Learn More →Expert pathology review, data interpretation, and technical guidance.
Learn More →Research protocols, documentation, and translational planning support.
Learn More →We review your study goals, available tissues, existing protocols, and constraints. This initial assessment identifies gaps, risks, and optimization opportunities.
We evaluate your current workflows, sample handling, assay performance, or pathology data quality. This identifies failure modes and decision points.
We deliver concrete outputs—protocols, SOPs, review reports, or workflow frameworks—with implementation guidance and follow-up support as needed.
Real-world examples of our pathology advisory work across diverse regions and applications.
Standardized tissue-handling SOPs for a multi-site US clinical trial to eliminate pre-analytical batch effects.
Troubleshot persistent non-specific staining for an exploratory biomarker panel, saving 4 weeks of rework.
Established image-to-case linkage protocols for a data-heavy translational program to ensure metadata integrity.
Optimized IHC protocols for a Korean-based oncology program moving to US Phase I.
Designed image management governance for a Middle Eastern biobanking initiative.
Troubleshot fixation-related assay failures for an APAC-based diagnostic developer.
For consulting inquiries, collaborations, or project discussions, reach out below.